|
Sign In to gain access to subscriptions and/or personal tools.
|
High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery
Michael W. Pantoliano
Millennium Pharmaceuticals Inc., Cambridge, MA
Eugene C. Petrella
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Joseph D. Kwasnoski
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Victor S. Lobanov
3-Dimensional Pharmaceuticals, Inc., Exton, PA
James Myslik
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Edward Graf
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Ted Carver
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Eric Asel
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Barry A. Springer
3-Dimensional Pharmaceuticals, Inc., Exton, PA
Pamela Lane
3-Dimensional Pharmaceuticals, Inc., Exton, PA
F. R. Salemme
3-Dimensional Pharmaceuticals, Inc., Exton, PA
More general and universally applicable drug discovery assay technologies are needed in order to keep pace with the recent advances in combinatorial chemistry and genomics-based target generation. Ligand-induced conformational stabilization of proteins is a well-understood phenomenon in which substrates, inhibitors, cofactors, and even other proteins provide enhanced stability to proteins on binding. This phenomenon is based on the energetic coupling of the ligand-binding and protein-melting reactions. In an attempt to harness these biophysical properties for drug discovery, fully automated instrumentation was designed and implemented to perform miniaturized fluorescence-based thermal shift assays in a microplate format for the high throughput screening of compound libraries. Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 protein targets. The general applicability of the thermal shift screening strategy was found to be an important advantage because it circumvents the need to design and retool new assays with each new therapeutic target. Moreover, the miniaturized thermal shift assay methodology does not require any prior knowledge of a therapeutic target's function, making it ideally suited for the quantitative high throughput drug screening and evaluation of targets derived from genomics.
Journal of Biomolecular Screening, Vol. 6, No. 6,
429-440 (2001)
DOI: 10.1177/108705710100600609

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Prochazkova, L. A. Shuvalova, G. Minasov, Z. Voburka, W. F. Anderson, and K. J. F. Satchell
Structural and Molecular Mechanism for Autoprocessing of MARTX Toxin of Vibrio cholerae at Multiple Sites
J. Biol. Chem.,
September 25, 2009;
284(39):
26557 - 26568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Korotkov, M. D. Gray, A. Kreger, S. Turley, M. Sandkvist, and W. G. J. Hol
Calcium Is Essential for the Major Pseudopilin in the Type 2 Secretion System
J. Biol. Chem.,
September 18, 2009;
284(38):
25466 - 25470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nag, Q. Ma, H. Wang, S. Chumnarnsilpa, W. L. Lee, M. Larsson, B. Kannan, M. Hernandez-Valladares, L. D. Burtnick, and R. C. Robinson
Ca2+ binding by domain 2 plays a critical role in the activation and stabilization of gelsolin
PNAS,
August 18, 2009;
106(33):
13713 - 13718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Malet, B. Coutard, S. Jamal, H. Dutartre, N. Papageorgiou, M. Neuvonen, T. Ahola, N. Forrester, E. A. Gould, D. Lafitte, et al.
The Crystal Structures of Chikungunya and Venezuelan Equine Encephalitis Virus nsP3 Macro Domains Define a Conserved Adenosine Binding Pocket
J. Virol.,
July 1, 2009;
83(13):
6534 - 6545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Crowther, A. J. Napuli, A. P. Thomas, D. J. Chung, K. V. Kovzun, D. J. Leibly, L. J. Castaneda, J. Bhandari, C. J. Damman, R. Hui, et al.
Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule Ligands
J Biomol Screen,
July 1, 2009;
14(6):
700 - 707.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Johnson, E. Hampton, and S. A. Lesley
The Thermotoga maritima Trk Potassium Transporter--from Frameshift to Function
J. Bacteriol.,
April 1, 2009;
191(7):
2276 - 2284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Hopper, A. M. C. Pittman, M. C. Fitzgerald, and C. L. Tucker
In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine:Glyoxylate Aminotransferase
J. Biol. Chem.,
November 7, 2008;
283(45):
30493 - 30502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Poranen, P. S. Salgado, M. R. L. Koivunen, S. Wright, D. H. Bamford, D. I. Stuart, and J. M. Grimes
Structural explanation for the role of Mn2+ in the activity of {phi}6 RNA-dependent RNA polymerase
Nucleic Acids Res.,
November 1, 2008;
36(20):
6633 - 6644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koszelak-Rosenblum, A. C. Krol, D. M. Simmons, C. C. Goulah, L. Wroblewski, and M. G. Malkowski
His-311 and Arg-559 Are Key Residues Involved in Fatty Acid Oxygenation in Pathogen-inducible Oxygenase
J. Biol. Chem.,
September 5, 2008;
283(36):
24962 - 24971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Senisterra, B. Soo Hong, H.-W. Park, and M. Vedadi
Application of High-Throughput Isothermal Denaturation to Assess Protein Stability and Screen for Ligands
J Biomol Screen,
June 1, 2008;
13(5):
337 - 342.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Attali, C. Frolet, C. Durmort, J. Offant, T. Vernet, and A. M. Di Guilmi
Streptococcus pneumoniae Choline-Binding Protein E Interaction with Plasminogen/Plasmin Stimulates Migration across the Extracellular Matrix
Infect. Immun.,
February 1, 2008;
76(2):
466 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Shieh, K. J. Mathis, J. M. Williams, R. L. Hills, J. F. Wiese, T. E. Benson, J. R. Kiefer, M. H. Marino, J. N. Carroll, J. W. Leone, et al.
High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2)
J. Biol. Chem.,
January 18, 2008;
283(3):
1501 - 1507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Z. Baum, S. M. Crespo-Carbone, A. Klinger, B. D. Foleno, I. Turchi, M. Macielag, and K. Bush
A MurF Inhibitor That Disrupts Cell Wall Biosynthesis in Escherichia coli
Antimicrob. Agents Chemother.,
December 1, 2007;
51(12):
4420 - 4426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Lorca, A. Ezersky, V. V. Lunin, J. R. Walker, S. Altamentova, E. Evdokimova, M. Vedadi, A. Bochkarev, and A. Savchenko
Glyoxylate and Pyruvate Are Antagonistic Effectors of the Escherichia coli IclR Transcriptional Regulator
J. Biol. Chem.,
June 1, 2007;
282(22):
16476 - 16491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Baumann, J. M. Eklof, G. Michel, A. M. Kallas, T. T. Teeri, M. Czjzek, and H. Brumer III
Structural Evidence for the Evolution of Xyloglucanase Activity from Xyloglucan Endo-Transglycosylases: Biological Implications for Cell Wall Metabolism
PLANT CELL,
June 1, 2007;
19(6):
1947 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ren, S. Sainsbury, S. E. Combs, R. G. Capper, P. W. Jordan, N. S. Berrow, D. K. Stammers, N. J. Saunders, and R. J. Owens
The Structure and Transcriptional Analysis of a Global Regulator from Neisseria meningitidis
J. Biol. Chem.,
May 11, 2007;
282(19):
14655 - 14664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Mezzasalma, J. K. Kranz, W. Chan, G. T. Struble, C. Schalk-Hihi, I. C. Deckman, B. A. Springer, and M. J. Todd
Enhancing Recombinant Protein Quality and Yield by Protein Stability Profiling
J Biomol Screen,
April 1, 2007;
12(3):
418 - 428.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schalk-Hihi, H.-C. Ma, G. T. Struble, S. Bayoumy, R. Williams, E. Devine, I. P. Petrounia, T. Mezzasalma, L. Zeng, C. Schubert, et al.
Protein Engineering of the Colony-stimulating Factor-1 Receptor Kinase Domain for Structural Studies
J. Biol. Chem.,
February 9, 2007;
282(6):
4085 - 4093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schubert, C. Schalk-Hihi, G. T. Struble, H.-C. Ma, I. P. Petrounia, B. Brandt, I. C. Deckman, R. J. Patch, M. R. Player, J. C. Spurlino, et al.
Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors
J. Biol. Chem.,
February 9, 2007;
282(6):
4094 - 4101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Senisterra, E. Markin, K. Yamazaki, R. Hui, M. Vedadi, and D. E. Awrey
Screening for Ligands Using a Generic and High-Throughput Light-Scattering-Based Assay
J Biomol Screen,
December 1, 2006;
11(8):
940 - 948.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vedadi, F. H. Niesen, A. Allali-Hassani, O. Y. Fedorov, P. J. Finerty Jr., G. A. Wasney, R. Yeung, C. Arrowsmith, L. J. Ball, H. Berglund, et al.
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination
PNAS,
October 24, 2006;
103(43):
15835 - 15840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Cummings, M. A. Farnum, and M. I. Nelen
Universal Screening Methods and Applications of ThermoFluor(R)
J Biomol Screen,
October 1, 2006;
11(7):
854 - 863.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Comess, M. E. Schurdak, M. J. Voorbach, M. Coen, J. D. Trumbull, H. Yang, L. Gao, H. Tang, X. Cheng, C. G. Lerner, et al.
An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF
J Biomol Screen,
October 1, 2006;
11(7):
743 - 754.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Magnusdottir, P. Stenmark, S. Flodin, T. Nyman, M. Hammarstrom, M. Ehn, M A. Bakali H, H. Berglund, and P. Nordlund
The Crystal Structure of a Human PP2A Phosphatase Activator Reveals a Novel Fold and Highly Conserved Cleft Implicated in Protein-Protein Interactions
J. Biol. Chem.,
August 11, 2006;
281(32):
22434 - 22438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Koblish, S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, et al.
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
Mol. Cancer Ther.,
January 1, 2006;
5(1):
160 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yanchunas Jr., D. R. Langley, L. Tao, R. E. Rose, J. Friborg, R. J. Colonno, and M. L. Doyle
Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors
Antimicrob. Agents Chemother.,
September 1, 2005;
49(9):
3825 - 3832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. El Omari, L. E. Bird, C. E. Nichols, J. Ren, and D. K. Stammers
Crystal Structure of CC3 (TIP30): IMPLICATIONS FOR ITS ROLE AS A TUMOR SUPPRESSOR
J. Biol. Chem.,
May 6, 2005;
280(18):
18229 - 18236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Carver, B. Bordeau, M. D. Cummings, E. C. Petrella, M. J. Pucci, L. E. Zawadzke, B. A. Dougherty, J. A. Tredup, J. W. Bryson, J. Yanchunas Jr., et al.
Decrypting the Biochemical Function of an Essential Gene from Streptococcus pneumoniae Using ThermoFluor(R) Technology
J. Biol. Chem.,
March 25, 2005;
280(12):
11704 - 11712.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|